Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nicotine Replacement Therapy Market Size study, by Product (Nicotine Replacement Therapy, E-cigarettes, Heat-not-burn tobacco products), Distribution Channel (Online and Offline) and Regional Forecasts 2020-2027

  • BIZ4259099
  • 200 Pages
  • March 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Nicotine Replacement Therapy Market is valued approximately at USD 38.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 16% over the forecast period 2020-2027. Nicotine Replacement Therapy is a treatment by which the craving for nicotine reduces, which helps people stop smoking and habits of chewing tobacco. The therapy uses products which has low doses of nicotine and do not contain toxins found in smoke. Government initiatives towards eliminating smoking habits, increase in number of people undergoing nicotine replacement therapies, insurance regulations, technological advancements, mergers and acquisitions by big market players are influencing market positively. In January 2017, British American Tobacco acquired 57.8% stakes in Reynolds American Inc. and makes it a wholly owned subsidiary of British American Tobacco. Also, in April 2020, US FDA authorized the marketing and distribution of a product developed by Philip Morris Products S.A., known as IQOS Tobacco Heating System, that is an electronic device which burn prefilled tobacco sticks to generate aerosols. However, ban on e-cigarettes in countries like India, Brazil, Mexico and others impedes the growth of the market over the forecast period of 2020-2027. Also, increasing awareness among people regarding harmful effects of smoking on body is likely to increase the market growth during the forecast period.

The regional analysis of global Nicotine Replacement Therapy market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increase in habit of cigarette smoking among adults and high availability of products of nicotine replacement therapy. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as high competition among tobacco companies and increasing demand for such products would create lucrative growth prospects for the Nicotine Replacement Therapy market across Asia-Pacific region.

Major market player included in this report are:

Cipla Inc.

Pfizer, Inc.

GLENMARK

Fertin Pharma

Philip Morris Products S.A.

British American Tobacco p.l.c.

Japan Tobacco, Inc.

Imperial Brands

Johnson & Johnson Services, Inc.

McNeil AB

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Nicotine Replacement Therapy

• Inhalers

• Gum

• Transdermal Patches

• Sublingual Tablets

• Lozenges

• Others

E-cigarettes

Heat-not-burn tobacco products

By Distribution Channel:

Online

Offline

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Nicotine Replacement Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Nicotine Replacement Therapy Market, by Region, 2018-2027 (USD Billion)

1.2.2. Nicotine Replacement Therapy Market, by Product, 2018-2027 (USD Billion)

1.2.3. Nicotine Replacement Therapy Market, by Distribution Channel, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Nicotine Replacement Therapy Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Nicotine Replacement Therapy Market Dynamics

3.1. Nicotine Replacement Therapy Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Nicotine Replacement Therapy Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economic

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Nicotine Replacement Therapy Market, by Product

5.1. Market Snapshot

5.2. Global Nicotine Replacement Therapy Market by Product, Performance - Potential Analysis

5.3. Global Nicotine Replacement Therapy Market Estimates & Forecasts by Product 2017-2027 (USD Billion)

5.4. Nicotine Replacement Therapy Market, Sub Segment Analysis

5.4.1. Nicotine Replacement Therapy

5.4.2. E-cigarettes

5.4.3. Heat-not-burn tobacco products

Chapter 6. Global Nicotine Replacement Therapy Market, by Distribution Channel

6.1. Market Snapshot

6.2. Global Nicotine Replacement Therapy Market by Distribution Channel, Performance - Potential Analysis

6.3. Global Nicotine Replacement Therapy Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)

6.4. Nicotine Replacement Therapy Market, Sub Segment Analysis

6.4.1. Online

6.4.2. Offline

Chapter 7. Global Nicotine Replacement Therapy Market, Regional Analysis

7.1. Nicotine Replacement Therapy Market, Regional Market Snapshot

7.2. North America Nicotine Replacement Therapy Market

7.2.1. U.S. Nicotine Replacement Therapy Market

7.2.1.1. Product breakdown estimates & forecasts, 2017-2027

7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027

7.2.1.3. Form breakdown estimates & forecasts, 2017-2027

7.2.1.4. Farm Product breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Nicotine Replacement Therapy Market

7.3. Europe Nicotine Replacement Therapy Market Snapshot

7.3.1. U.K. Nicotine Replacement Therapy Market

7.3.2. Germany Nicotine Replacement Therapy Market

7.3.3. France Nicotine Replacement Therapy Market

7.3.4. Spain Nicotine Replacement Therapy Market

7.3.5. Italy Nicotine Replacement Therapy Market

7.3.6. Rest of Europe Nicotine Replacement Therapy Market

7.4. Asia-Pacific Nicotine Replacement Therapy Market Snapshot

7.4.1. China Nicotine Replacement Therapy Market

7.4.2. India Nicotine Replacement Therapy Market

7.4.3. Japan Nicotine Replacement Therapy Market

7.4.4. Australia Nicotine Replacement Therapy Market

7.4.5. South Korea Nicotine Replacement Therapy Market

7.4.6. Rest of Asia Pacific Nicotine Replacement Therapy Market

7.5. Latin America Nicotine Replacement Therapy Market Snapshot

7.5.1. Brazil Nicotine Replacement Therapy Market

7.5.2. Mexico Nicotine Replacement Therapy Market

7.6. Rest of The World Nicotine Replacement Therapy Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Cipla Inc.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Pfizer, Inc.

8.2.3. GLENMARK

8.2.4. Fertin Pharma

8.2.5. Philip Morris Products S.A.

8.2.6. British American Tobacco p.l.c.

8.2.7. Japan Tobacco, Inc.

8.2.8. Imperial Brands

8.2.9. Johnson & Johnson Services, Inc.

8.2.10. McNeil AB

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Nicotine Replacement Therapy market, report scope

TABLE 2. Global Nicotine Replacement Therapy market estimates & forecasts by Region 2017-2027 (USD Billion)

TABLE 3. Global Nicotine Replacement Therapy market estimates & forecasts by Product 2017-2027 (USD Billion)

TABLE 4. Global Nicotine Replacement Therapy market estimates & forecasts by Distribution Channel 2017-2027 (USD Billion)

TABLE 5. Global Nicotine Replacement Therapy market estimates & forecasts by Form 2017-2027 (USD Billion)

TABLE 6. Global Nicotine Replacement Therapy market estimates & forecasts by Farm Product 2017-2027 (USD Billion)

TABLE 7. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. U.S. Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. U.S. Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 19. U.S. Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 20. Canada Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. Canada Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 22. Canada Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 23. UK Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 24. UK Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 25. UK Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Germany Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 27. Germany Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 28. Germany Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. RoE Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 30. RoE Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 31. RoE Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. China Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 33. China Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 34. China Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. India Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 36. India Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 37. India Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Japan Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 39. Japan Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 40. Japan Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. RoAPAC Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 42. RoAPAC Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 43. RoAPAC Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. Brazil Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 45. Brazil Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 46. Brazil Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. Mexico Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 48. Mexico Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 49. Mexico Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. RoLA Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 51. RoLA Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 52. RoLA Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Row Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 54. Row Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 55. Row Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 56. List of secondary sources, used in the study of global Nicotine Replacement Therapy market

TABLE 57. List of primary sources, used in the study of global Nicotine Replacement Therapy market

TABLE 58. Years considered for the study

TABLE 59. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390